DO YOU ALL THINK THAT CHINA RAPIMEDS WILL BE A HUGE HIT AND

New Post Public Reply Private Reply Replies (3) Message Board
tryz
DO YOU ALL THINK THAT CHINA RAPIMEDS WILL BE A HUGE HIT AND REVENUE IMPACT FOR SCRC???....JUST LOOK AT THIS TOXIC GARBAGE THEY ARE SELLING TO THERE CHILDREN NOW ! >.....

independent, evidence-based medical news from China | by michael woodhead

Thursday, 31 January 2013

In China, celebrities think twice about selling snake oil

Song Dandan (???) promoted OTC remedy linked to liver toxicity
A Chinese actress who endorsed a cold remedy for children, which according to rumors swirling around microblogs is "proven to be poisonous to children's livers," has received unexpected praise after stating that she will never again endorse any medicine products.
The claim, made by sitcom actress Song Dandan (???) on Friday, has led to public debate over whether celebrities should be involved in promoting medicine, though the company has denied the medicine is harmful. Song made these statements after reading a popular microblog thread that stated that Youkadan, a cold remedy for children produced by the Renhe Group in Jiangxi Province, is dangerous to children's livers. The company has now changed the medicine's instructions to explicitly state it should not be used on children below one year old.
"I'm surprised to hear that Youkadan is harmful to children's health. My agent and I were extremely cautious when considering endorsing this medicine and we had heard that the manufacturer and medicine authorities had done comprehensive checks of the medicine," Song said on her microblog.
"If the claim on the Internet is true, I will sincerely apologize to customers through the media," she said, swearing that she will never again endorse any medicine products as she could not be sure of the products' true quality and nature.
The Renhe Group said on Saturday that they had changed Youkadan's medical instructions according to a State Food and Drug Administration's notice regarding drugs that contain adamantanamine hydrochloride.
Youkadan is not poisonous to children's livers, the Renhe Group claimed, adding that the administration decided to ban the use of the adamantanamine on children below one year old "due to a lack of evidence determining the effect and safety of the adamantanamine on the age group."
Though the Renhe Group's reputation has been cleared by the authorities, the episode nevertheless led to appeals that celebrities should refrain from endorsing food and medical products.
Song, who has played the role of a caring, responsible mother in sitcoms, also won the public's sympathy as she was one of the few celebrities that stood out and tried to shoulder her responsibility for endorsing a brand.
"I think Song's oath not to endorse medical products anymore is very responsible, because celebrities have a huge influence but don't have the means to check whether the products would be harmful to people," Hu Yuan, a pregnant woman in Beijing, said. "Celebrities should not abuse their influence to pursue personal wealth," she added.
"It's fine for celebrities to endorse any product they wish because it is not their job to determine a product's quality. But given the food safety issues and irregularities in China's medical and health care product markets, they should protect their reputation and not endorse products that look fishy," Shen Dong, a TV director in Beijing, told the Global Times.
On May 26, 2009, a legal interpretation was issued from the Supreme People's Court and Supreme People's Procuratorate, stipulating that any individuals that assist in the sale of fake drugs by advertising them will be treated as accomplices.
When dealing with drug advertisements, celebrities should not only check the medicine's drug approval number, but also consult professionals to check the credentials of the medicine and its producers' qualifications and quality, Zhang Yongjian, a food and drug expert with the Chinese Academy of Social Sciences, told the Global Times.
In April 2012, the Xiuzheng Pharmaceutical Group, a leading Chinese drug maker, was revealed to have been buying capsules containing toxic chemicals made by illegal drug makers. Though all the medicines involved had received approval from the authorities, the ten celebrities were still criticized for abusing their influence to endorse Xiuzheng's products.
Source : Global Times

Friday, 4 January 2013

Chinese rush to buy non-prescription drugs overseas

As more Chinese tourists travel overseas, they are also bringing back non-prescription drugs and vitamin supplements purchased on their trips, the Chinese-language Guangzhou Daily reported.
Many people in China are firm believers in taking drugs and supplements for their health, which is why such products often appeared on their shopping lists when they go abroad, the newspaper said.
Vitamin supplements sold in Europe are highly sought-after, such as Altapharma products, which can be found in several supermarket chains in Germany, the newspaper said. Another popular European drug is Fluimucil A, which is used to treat wet coughs.
Besides vitamins, most medicinal products bought by Chinese visitors to Japan are those used for children, including cold medicine, cooling sheets for children with a fever, and seirogan — a drug used to treat digestive problems.
Japan is also well-known for selling a vast variety of patches that ease muscle soreness, including those that create a cooling effect and those which produce a warm sensation. Compared with similar products in China that often give off a bad odor, the Japanese versions are easy to peel away and are scented, the newspaper said.
Several drugs sold in Thailand are also popular among Chinese visitors, including Siribuncha's and Povidone-lodine's solution for treating burns and cuts, and Ya Hom Powder of Five Pagodas Pharmacy, which can be used for treating stomach ailments and motion sickness.
Another popular product sold in several Southeast Asian countries is Tiger Balm, an ointment used for treating bug bites, headaches, a stuffy nose, motion sickness and sore muscles as well as sundry other purposes.
Source: Want China Times

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 5

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
FuelCell's Class Action: Investors' Deadline Approaching

Updated Category News Views 26

One Rough Ride for FuelCell Investors Sometimes the market feels like a roller coaster stuck on the down-hill plunge, and right now, FuelCell Energy (NASDAQ: FCEL) investors are gripping their harnesses. The latest turmoil has investors looking at a tight November 10 deadline to decide if they want in on the securities class action shaking the ground beneath FCEL. Looming...

Continue Reading
CapCut's AI Tools Revolutionize Visual Content Creation

Updated Category News Views 15

Riding the AI Content Creation Wave You know, once upon a time, crafting stunning visual content was a task that had creatives burning the midnight oil. But these days, it seems like artificial intelligence is shaking things up—and CapCut's sitting pretty at the helm of this revolution. Recently, Consumer365 gave CapCut a nod as a top contender for visual content...

Continue Reading
LifeSecure Expands with Starscape Agency Launch

Updated Category News Views 2

LifeSecure's Strategic Move into the Insurance Space LifeSecure Holdings Corporation is planting new roots with its latest venture, Starscape Insurance Agency. This ain't just another splash in the kiddie pool, buddy. This is a big step in bolstering its standing in the insurance sector, focusing sharply on health insurance solutions for individuals, families, and even...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 6

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading
Mendocino Farms Faces Allegations Over Employee Practices

Updated Category News Views 8

Mendocino Farms Lands in Legal Hot Water Jobs pay the bills and keep the gears turning. But when a company like Mendocino Farms allegedly chucks out the rulebook, things get messy fast. We're talking about a hefty lawsuit aimed at this chain, accusing them of playing fast and loose with California's labor laws. If you've been around the block like me, you know that...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 25

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 18

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Palmstreet Amplifies Designer Toys at Las Vegas Con

Updated Category News Views 9

Designer Toys Take the Spotlight Palmstreet's latest move into the designer toy world is buzzing with anticipation. This live-shopping app, initially catering to rare plants, is taking its evolution seriously with another plunge into exclusive collectibles, this time showcasing unique collaborations at DesignerCon in Las Vegas. While Palmstreet may have started in a...

Continue Reading
Understanding New Jersey's Gun Laws Through Legal Eyes

Updated Category News Views 7

Cracking New Jersey's Complex Legal Code You ever try to decode the rulebook judges play by when gun possession and aggravated assault enter the picture in New Jersey? Well, it's as tricky as picking a safe with a wet noodle. Thankfully, a legal eagle named Ed Weinstock sheds some light on this murky terrain. Now, this isn't just some academic exercise—it's a look into...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Market Moves: What Lies Beneath Today's Trends?

Updated Category News Views 296

Understanding Recent Stock Market Movements The stock market has recently shown signs of subtle shifts, with many stocks closing the day positively. For instance, the S&P 500 experienced a rise of approximately 0.50%, while the NASDAQ 100 followed closely with a 0.25% increase. Such increases come amidst an intriguing rotation within the S&P 500, where a significant...

Continue Reading
Sage Park Guadalupe: A New Era in Senior Living Management

Updated Category News Views 148

Sage Park Guadalupe: A Fresh Start in Senior Living Watercrest Senior Living Group has been awarded new management for the community formerly known as Juniper Village at Guadalupe Riverfront. This shift marks a significant change in operational leadership, as the community embarks on a fresh new branding journey under the name Sage Park Guadalupe. Expansion and Rebranding...

Continue Reading
Transforming $1000 in Spotify Technology into Substantial Gains

Updated Category News Views 181

Transform Your Investment with Spotify Technology Spotify Technology (NYSE: SPOT) has been an impressive player in the market, showcasing remarkable growth that outpaces many competitors. Over the past five years, it has outperformed the broader market by 10.11% annually, achieving an outstanding average annual return of 25.02%. With a current market capitalization of...

Continue Reading
Murphy Oil Corporation Appoints Eric M. Hambly as CEO

Updated Category News Views 159

Murphy Oil Corporation made a major leadership change, appointing Eric M. Hambly as the new President and CEO back in 2025, taking over from Roger W. Jenkins who had led the company since 2013. This move wasn't just a shuffle; it signified a pivotal transition for a firm navigating the choppy waters of the oil market. Leadership Change: What Does It Mean for Murphy Oil?...

Continue Reading
Adial Pharmaceuticals Secures $2.75 Million Through Warrant Exercise

Updated Category News Views 197

Adial Pharmaceuticals Announces Warrant Inducement Transaction Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a dedicated biopharmaceutical company focused on combating addiction and related disorders, recently entered into an agreement for a warrant inducement. This transaction is projected to generate approximately $2.75 million in gross proceeds, aimed at fortifying the...

Continue Reading